Verona Pharma【VRNA】株式ニュース

名称	銘柄コード	市場	種別
Verona Pharma Plc	VRNA	NASDAQ	Depository Receipt

	前日比	前日比 %	現在値	時刻
	0.59	5.14%	12.07	06:58:45

始値	安値	高値	終値	前日終値
11.55	11.4548	12.546	12.07	11.48

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/10	22:09	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/10	21:53	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2024/5/09	20:22	EDGAR2	Form 8-K - Current report
2024/5/09	20:18	EDGAR2	Form 8-K - Current report
2024/5/09	20:15	GLOBE	Verona Pharma Reports First Quarter 2024 Financial Results..
2024/5/09	20:00	GLOBE	Verona Pharma Announces $650 Million Strategic..
2024/5/02	15:00	GLOBE	Verona Pharma to Present Additional Analyses of Positive..
2024/4/25	15:00	GLOBE	Verona Pharma to Report First Quarter 2024 Financial Results..
2024/3/09	06:18	EDGAR2	Form PRE 14A - Other preliminary proxy statements
2024/3/08	11:40	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2024/3/04	16:00	GLOBE	Andrew Fisher Joins Verona Pharma as General Counsel
2024/2/29	23:00	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/29	20:08	EDGAR2	Form 8-K - Current report
2024/2/29	16:00	GLOBE	Verona Pharma Reports Fourth Quarter and Full Year 2023..
2024/2/15	16:00	GLOBE	Verona Pharma to Report Fourth Quarter and Full Year 2023..
2024/2/06	08:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/06	08:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/06	06:19	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/02	20:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/02	20:05	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2024/2/02	20:02	EDGAR2	Form 8-K - Current report
2024/2/01	16:00	GLOBE	Michael Austwick Joins Verona Pharma as Non-Executive..
2024/1/03	16:00	GLOBE	Verona Pharma to Present at 42nd Annual J.P. Morgan..
2024/1/02	20:02	EDGAR2	Form 8-K - Current report
2024/1/02	16:00	GLOBE	Verona Pharma enters into Debt Facility of up to $400..
2023/12/19	06:15	EDGAR2	Form 8-K - Current report
2023/11/17	16:00	GLOBE	Verona Pharma’s President and CEO David Zaccardelli Wins..
2023/11/08	16:00	GLOBE	Verona Pharma Announces November 2023 Investor Conference..
2023/11/04	09:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/04	09:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/04	05:25	EDGAR2	Form 144 - Report of proposed sale of securities
2023/11/03	05:16	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/02	19:24	EDGAR2	Form 8-K - Current report
2023/11/02	16:04	GLOBE	Verona Pharma Reports Third Quarter 2023 Financial Results..
2023/10/25	05:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/10/25	05:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/10/19	15:00	GLOBE	Verona Pharma to Report Third Quarter 2023 Financial Results..
2023/10/06	15:00	GLOBE	Verona Pharma to Host Investor Update on Commercialization..
2023/10/03	15:00	GLOBE	Verona Pharma to Present Additional Analyses of Positive..
2023/9/11	19:02	EDGAR2	Form 8-K - Current report
2023/9/11	15:00	GLOBE	Verona Pharma Announces the US FDA has Accepted the New Drug..
2023/9/06	15:00	GLOBE	Verona Pharma to Present Additional Analysis of Phase 3..
2023/9/06	05:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/06	05:05	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2023/9/02	05:05	EDGAR2	Form 8-K - Current report
2023/8/31	15:00	GLOBE	Christina Ackermann Joins Verona Pharma as Non-Executive..
2023/8/08	10:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/08	10:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/04	09:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/04	09:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..